Cargando…

EMT in Breast Carcinoma—A Review

The epithelial to mesenchymal transition (EMT) is a cellular program that is involved in embryonic development; wound healing, but also in tumorigenesis. Breast carcinoma (BC) is the most common cancer in women worldwide, and the majority of deaths (90%) are caused by invasion and metastasis. The EM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felipe Lima, Joema, Nofech-Mozes, Sharon, Bayani, Jane, Bartlett, John M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961996/ https://www.ncbi.nlm.nih.gov/pubmed/27429011 http://dx.doi.org/10.3390/jcm5070065

Ejemplares similares

61. EXPRESSION OF ANDROGEN RECEPTOR IN BREAST CANCER BRAIN METASTASIS
por: Qazi, Maleeha, et al.
Publicado: (2020)

Retroperitoneal Extraovarian Fibrothecoma Mimicking a Malignant Epithelial Ovarian Carcinoma
por: Roberts, Patrick, et al.
Publicado: (2012)

HER2-LOW BREAST CANCER BRAIN METASTASES: INCIDENCE AND TREATMENT IMPLICATIONS
por: Chehade, Rania, et al.
Publicado: (2023)

MLH1 Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal
por: Plotkin, Anna, et al.
Publicado: (2023)

Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2(+):ERα(-) breast cancer
por: Liu, Jeffrey C., et al.
Publicado: (2017)

Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent
por: Fan, Kevin Yijun, et al.
Publicado: (2023)

A Cluster-then-label Semi-supervised Learning Approach for Pathology Image Classification
por: Peikari, Mohammad, et al.
Publicado: (2018)

PD-L1 expression in breast cancer brain metastases
por: Chehade, Rania, et al.
Publicado: (2022)

Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?
por: Hahn, Ezra, et al.
Publicado: (2023)

Intraoperative Assessment of Sentinel Lymph Nodes in Breast Cancer Patients Post-Neoadjuvant Therapy
por: Wong, Willard, et al.
Publicado: (2019)

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
por: Rakovitch, E, et al.
Publicado: (2012)

Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force
por: Faragalla, Hala, et al.
Publicado: (2023)

Pan-cancer classification of single cells in the tumour microenvironment
por: Nofech-Mozes, Ido, et al.
Publicado: (2023)

SPIE-AAPM-NCI BreastPathQ Challenge: an image analysis challenge for quantitative tumor cellularity assessment in breast cancer histology images following neoadjuvant treatment
por: Petrick, Nicholas, et al.
Publicado: (2021)

Syndecan-1 (CD138), Carcinomas and EMT
por: Couchman, John R.
Publicado: (2021)

Automated and Manual Quantification of Tumour Cellularity in Digital Slides for Tumour Burden Assessment
por: Akbar, Shazia, et al.
Publicado: (2019)

Overcoming the limitations of patch-based learning to detect cancer in whole slide images
por: Ciga, Ozan, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation
por: Voutsadakis, Ioannis A.
Publicado: (2016)

Quantitative single-cell analysis of immunofluorescence protein multiplex images illustrates biomarker spatial heterogeneity within breast cancer subtypes
por: Cheung, Alison Min-Yan, et al.
Publicado: (2021)

miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1
por: Butz, Henriett, et al.
Publicado: (2015)

Partial EMT in Squamous Cell Carcinoma: A Snapshot
por: Liao, Chengcheng, et al.
Publicado: (2021)

High Expression of RECQL Protein in ER-Positive Breast Tumours Is Associated With a Better Survival
por: Mahmoodi, Ardalan, et al.
Publicado: (2022)

Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis
por: Butz, Henriett, et al.
Publicado: (2017)

Tumor Budding: The Name is EMT. Partial EMT.
por: Grigore, Alexandru Dan, et al.
Publicado: (2016)

FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
por: Casalino, Laura, et al.
Publicado: (2023)

Biological Markers Predictive of Invasive Recurrence in DCIS
por: Nofech-Mozes, Sharon, et al.
Publicado: (2008)

MicroRNA‐194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma
por: Nofech‐Mozes, Roy, et al.
Publicado: (2016)

Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
por: Pal, Ajay Kumar, et al.
Publicado: (2022)

Interobserver Agreement for Endometrial Cancer Characteristics Evaluated on Biopsy Material
por: Nofech-Mozes, S., et al.
Publicado: (2012)

The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas
por: Sánchez-Tilló, Ester, et al.
Publicado: (2023)

Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
por: De Francesco, Ernestina M., et al.
Publicado: (2018)

A “NOTCH” Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer
por: Kar, Rohan, et al.
Publicado: (2019)

Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2022)

EMT and tumor metastasis
por: Heerboth, Sarah, et al.
Publicado: (2015)

Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis
por: Imani, Saber, et al.
Publicado: (2016)

Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer
por: Helpman, L, et al.
Publicado: (2014)

Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT
por: Parvani, Jenny G, et al.
Publicado: (2013)

Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells
por: Charpentier, Monica, et al.
Publicado: (2013)

New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
por: Khaled, Noura, et al.
Publicado: (2019)

Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer
por: Wu, Hua-Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k772tmrd4316j4iuic5cj5tdh2